Children and young people who are Black or Hispanic are less likely to be diagnosed with migraine than those who are white ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

Children and young people who are Black or Hispanic are less likely to be diagnosed with migraine than those who are white ...

The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...

"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

A study published in The Lancet found that sodium nitrite provoked headaches in eight out of 13 people who consumed it.

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Lying alone, in the dark, Leigh Shulman tried willing away the blinding migraine pain that had forced her to skip meeting ...